GetTopicDetailResponse(id=3fe8e1618e2, topicName=白三烯受體拮抗劑, introduction=白三烯受體拮抗劑, content=null, image=null, comments=3, allHits=1099, url=https://h5.medsci.cn/topic?id=71618, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=5577, tagList=[TagDto(tagId=5577, tagName=白三烯受體拮抗劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2067041, encodeId=f7ff206e041a6, content=<a href='/topic/show?id=3fe8e1618e2' target=_blank style='color:#2F92EE;'>#白三烯受體拮抗劑#</a>, objectTitle=Allergy Asthma Clin Immunol：白三烯受體拮抗劑與選擇性H1-抗組胺藥治療過敏性鼻炎：當前證據(jù)的元分析, objectType=article, longId=214560, objectId=d7032145600f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7032145600f, replyNumber=0, likeNumber=109, createdTime=2021-10-19, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7032145600f, moduleTitle=Allergy Asthma Clin Immunol：白三烯受體拮抗劑與選擇性H1-抗組胺藥治療過敏性鼻炎：當前證據(jù)的元分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d7032145600f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2067040, encodeId=d180206e0404d, content=<a href='/topic/show?id=3fe8e1618e2' target=_blank style='color:#2F92EE;'>#白三烯受體拮抗劑#</a>, objectTitle=2016白三烯受體拮抗劑在兒童常見呼吸系統(tǒng)疾病中的臨床應用專家共識發(fā)布, objectType=article, longId=74568, objectId=f60de456844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f60de456844, replyNumber=0, likeNumber=78, createdTime=2017-02-10, rootId=0, userName=12498e5fm12(暫無昵稱), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f60de456844, moduleTitle=2016白三烯受體拮抗劑在兒童常見呼吸系統(tǒng)疾病中的臨床應用專家共識發(fā)布, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f60de456844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2067039, encodeId=d87b206e0392a, content=<a href='/topic/show?id=3fe8e1618e2' target=_blank style='color:#2F92EE;'>#白三烯受體拮抗劑#</a>, objectTitle=Cochrane Database Syst Rev:口服白三烯受體拮抗劑治療哮喘急性發(fā)作缺乏證據(jù), objectType=article, longId=8419, objectId=cc628419f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc628419f0, replyNumber=0, likeNumber=95, createdTime=2012-09-08, rootId=0, userName=12498e5fm12(暫無昵稱), userId=793a2500200, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc628419f0, moduleTitle=Cochrane Database Syst Rev:口服白三烯受體拮抗劑治療哮喘急性發(fā)作缺乏證據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cc628419f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
